Oxcarbazepine Monotherapy
The efficacy of oxcarbazepine monotherapy in 60 children and adolescents (aged 6 months to 17.8 years; mean age 8.2 yrs) with partial onset epilepsy was evaluated by retrospective chart review in a study at St Christopher’s Hospital for Children, Philadelphia, PA.
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
2006-10-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/1106 |